Differential expression of group I metabotropic glutamate receptors in human motoneurons at low and high risk of degeneration in amyotrophic lateral sclerosis

Neuroscience

Volumn 143, Issue 1, 2006, Pages 95-104

  Ma, L ^a   Ostrovsky, H ^a   Miles, G ^a   Lipski, J ^a   Funk, G D ^a   Nicholson, L F B ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

excitotoxicity; glia; motor nucleus

Indexed keywords

METABOTROPIC RECEPTOR 1; METABOTROPIC RECEPTOR 5;

AMYOTROPHIC LATERAL SCLEROSIS; ANTIBODY LABELING; ARTICLE; BRAIN; CELL DEGENERATION; CERVICAL SPINAL CORD; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; MOTONEURON; MOTONEURON NUCLEUS; OPTICAL DENSITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RISK;

CENTRAL NERVOUS SYSTEM; CHOLINE O-ACETYLTRANSFERASE; GENE EXPRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MOTOR NEURONS; POSTMORTEM CHANGES; RECEPTORS, METABOTROPIC GLUTAMATE;

EID: 33750533168     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2006.07.058     Document Type: Article

References (62)

1. Abe K., Pan L.H., Watanabe M., Konno H., Kato T., and Itoyama Y. Upregulation of protein-tyrosine nitration in the anterior horn cells of amyotrophic lateral sclerosis. Neurol Res 19 (1997) 124-128
2. Alberts B., Bray D., Lewis J., Raff M., Roberts K., and Watson J.D. Molecular biology of the cell (1994), Garling Publishing Inc, New York
3. Anneser J.M., Borasio G.D., Berthele A., Zieglgansberger W., and Tolle T.R. Differential expression of group I metabotropic glutamate receptors in rat spinal cord somatic and autonomic motoneurons: possible implications for the pathogenesis of amyotrophic lateral sclerosis. Neurobiol Dis 6 (1999) 140-147
4. Anneser J.M., Chahli C., Ince P.G., Borasio G.D., and Shaw P.J. Glial proliferation and metabotropic glutamate receptor expression in amyotrophic lateral sclerosis. J Neuropathol Exp Neurol 63 (2004) 831-840
5. Anneser J.M., Ince P.G., Shaw P.J., and Borasio G.D. Differential expression of mGluR5 in human lumbosacral motoneurons. Neuroreport 15 (2004) 271-273
6. Aronica E., Catania M.V., Geurts J., Yankaya B., and Troost D. Immunohistochemical localization of group I and II metabotropic glutamate receptors in control and amyotrophic lateral sclerosis human spinal cord: upregulation in reactive astrocytes. Neuroscience 105 (2001) 509-520
7. Biber K., Laurie D.J., Berthele A., Sommer B., Tolle T.R., Gebicke-Harter P.J., van Calker D., and Boddeke H.W. Expression and signaling of group I metabotropic glutamate receptors in astrocytes and microglia. J Neurochem 72 (1999) 1671-1680
8. Bordi F., and Ugolini A. Group I metabotropic glutamate receptors: implications for brain diseases. Prog Neurobiol 59 (1999) 55-79
9. Brown Jr. R.H. Amyotrophic lateral sclerosis: recent insights from genetics and transgenic mice. Cell 80 (1995) 687-692
10. Bruno V., Battaglia G., Kingston A., O'Neill M.J., Catania M.V., Di Grezia R., and Nicoletti F. Neuroprotective activity of the potent and selective mGlu1a metabotropic glutamate receptor antagonist, (+)-2-methyl-4 carboxyphenylglycine (LY367385): comparison with LY357366, a broader spectrum antagonist with equal affinity for mGlu1a and mGlu5 receptors. Neuropharmacology 38 (1999) 199-207
11. Calabresi P., Centonze D., Pisani A., and Bernardi G. Metabotropic glutamate receptors and cell-type-specific vulnerability in the striatum: implication for ischemia and Huntington's disease. Exp Neurol 158 (1999) 97-108
12. Calabresi P., Centonze D., Pisani A., Sancesario G., Gubellini P., Marfia G.A., and Bernardi G. Striatal spiny neurons and cholinergic interneurons express differential ionotropic glutamatergic responses and vulnerability: implications for ischemia and Huntington's disease. Ann Neurol 43 (1998) 586-597
13. Ciccarelli R., Sureda F.X., Casabona G., Di Iorio P., Caruso A., Spinella F., Condorelli D.F., Nicoletti F., and Caciagli F. Opposite influence of the metabotropic glutamate receptor subtypes mGlu3 and -5 on astrocyte proliferation in culture. Glia 21 (1997) 390-398
14. Cleveland D.W., and Rothstein J.D. From Charcot to Lou Gehrig: deciphering selective motor neuron death in ALS. Nat Rev Neurosci 2 (2001) 806-819
15. Condorelli D.F., Dell'Albani P., Corsaro M., Giuffrida R., Caruso A., Trovato Salinaro A., Spinella F., Nicoletti F., Albanese V., and Giuffrida Stella A.M. Metabotropic glutamate receptor expression in cultured rat astrocytes and human gliomas. Neurochem Res 22 (1997) 1127-1133
16. DePaul R., Abbs J.H., Caligiuri M., Gracco V.L., and Brooks B.R. Hypoglossal, trigeminal, and facial motoneuron involvement in amyotrophic lateral sclerosis. Neurology 38 (1988) 281-283
17. Desai M.A., Burnett J.P., Mayne N.G., and Schoepp D.D. Cloning and expression of a human metabotropic glutamate receptor 1 alpha: enhanced coupling on co-transfection with a glutamate transporter. Mol Pharmacol 48 (1995) 648-657
18. Francesconi A., and Duvoisin R.M. Opposing effects of protein kinase C and protein kinase A on metabotropic glutamate receptor signaling: selective desensitization of the inositol trisphosphate/Ca2+ pathway by phosphorylation of the receptor-G protein-coupling domain. Proc Natl Acad Sci U S A 97 (2000) 6185-6190
19. Gegelashvili G., Dehnes Y., Danbolt N.C., and Schousboe A. The high-affinity glutamate transporters GLT1, GLAST, and EAAT4 are regulated via different signaling mechanisms. Neurochem Int 37 (2000) 163-170
20. Gizzi M., DiRocco A., Sivak M., and Cohen B. Ocular motor function in motor neuron disease. Neurology 42 (1992) 1037-1046
21. Hall E.D., Oostveen J.A., and Gurney M.E. Relationship of microglial and astrocytic activation to disease onset and progression in a transgenic model of familial ALS. Glia 23 (1998) 249-256
22. Hasham M.I., Naumann D., Kim S.U., Cashman N.R., Quamme G.A., and Krieger C. Intracellular calcium concentrations during metabolic inhibition in the motoneuron cell line NSC-19. Can J Physiol Pharmacol 72 (1994) 728-737
23. Hay M., McKenzie H., Lindsley K., Dietz N., Bradley S.R., Conn P.J., and Hasser E.M. Heterogeneity of metabotropic glutamate receptors in autonomic cell groups of the medulla oblongata of the rat. J Comp Neurol 403 (1999) 486-501
24. Heath P.R., Tomkins J., Ince P.G., and Shaw P.J. Quantitative assessment of AMPA receptor mRNA in human spinal motor neurons isolated by laser capture microdissection. Neuroreport 13 (2002) 1753-1757
25. Hermans E., and Challiss R.A. Structural, signalling and regulatory properties of the group I metabotropic glutamate receptors: prototypic family C G-protein-coupled receptors. Biochem J 359 (2001) 465-484
26. Howland D.S., Liu J., She Y., Goad B., Maragakis N.J., Kim B., Erickson J., Kulik J., DeVito L., Psaltis G., DeGennaro L.J., Cleveland D.W., and Rothstein J.D. Focal loss of the glutamate transporter EAAT2 in a transgenic rat model of SOD1 mutant-mediated amyotrophic lateral sclerosis (ALS). Proc Natl Acad Sci U S A 99 (2002) 1604-1609
27. Ince P., Stout N., Shaw P., Slade J., Hunziker W., Heizmann C.W., and Baimbridge K.G. Parvalbumin and calbindin D-28k in the human motor system and in motor neuron disease. Neuropathol Appl Neurobiol 19 (1993) 291-299
28. Ince P.G., Lowe J., and Shaw P.J. Amyotrophic lateral sclerosis: current issues in classification, pathogenesis and molecular pathology. Neuropathol Appl Neurobiol 24 (1998) 104-117
29. Jackson C.E., and Bryan W.W. Amyotrophic lateral sclerosis. Semin Neurol 18 (1998) 27-39
30. Janssens N., and Lesage A.S. Glutamate receptor subunit expression in primary neuronal and secondary glial cultures. J Neurochem 77 (2001) 1457-1474
31. Krieger C., Jones K., Kim S.U., and Eisen A.A. The role of intracellular free calcium in motor neuron disease. J Neurol Sci 124 Suppl (1994) 27-32
32. Laslo P., Lipski J., and Funk G.D. Differential expression of group I metabotropic glutamate receptors in motoneurons at low and high risk for degeneration in ALS. Neuroreport 12 (2001) 1903-1908
33. Laslo P., Lipski J., Nicholson L.F., Miles G.B., and Funk G.D. GluR2 AMPA receptor subunit expression in motoneurons at low and high risk for degeneration in amyotrophic lateral sclerosis. Exp Neurol 169 (2001) 461-471
34. Levine J.B., Kong J., Nadler M., and Xu Z. Astrocytes interact intimately with degenerating motor neurons in mouse amyotrophic lateral sclerosis (ALS). Glia 28 (1999) 215-224
35. Lin C.L., Bristol L.A., Jin L., Dykes-Hoberg M., Crawford T., Clawson L., and Rothstein J.D. Aberrant RNA processing in a neurodegenerative disease: the cause for absent EAAT2, a glutamate transporter, in amyotrophic lateral sclerosis. Neuron 20 (1998) 589-602
36. Llinas R., Sugimori M., Cherksey B.D., Smith R.G., Delbono O., Stefani E., and Appel S. IgG from amyotrophic lateral sclerosis patients increases current through P-type calcium channels in mammalian cerebellar Purkinje cells and in isolated channel protein in lipid bilayer. Proc Natl Acad Sci U S A 90 (1993) 11743-11747
37. Ma L., Carter R.J., Morton A.J., and Nicholson L.F. RAGE is expressed in pyramidal cells of the hippocampus following moderate hypoxic-ischemic brain injury in rats. Brain Res 966 (2003) 167-174
38. McDonald J.W., Fix A.S., Tizzano J.P., and Schoepp D.D. Seizures and brain injury in neonatal rats induced by 1S,3R-ACPD, a metabotropic glutamate receptor agonist. J Neurosci 13 (1993) 4445-4455
39. McDonald J.W., and Schoepp D.D. The metabotropic excitatory amino acid receptor agonist 1S,3R-ACPD selectively potentiates N-methyl-D-aspartate-induced brain injury. Eur J Pharmacol 215 (1992) 353-354
40. Miller T.M., and Cleveland D.W. Treating neurodegenerative diseases with antibiotics. Science 307 (2005) 361-362
41. Minakami R., Katsuki F., Yamamoto T., Nakamura K., and Sugiyama H. Molecular cloning and the functional expression of two isoforms of human metabotropic glutamate receptor subtype 5. Biochem Biophys Res Commun 199 (1994) 1136-1143
42. Moroni F., Lombardi G., Thomsen C., Leonardi P., Attucci S., Peruginelli F., Torregrossa S.A., Pellegrini-Giampietro D.E., Luneia R., and Pellicciari R. Pharmacological characterization of 1-aminoindan-1,5-dicarboxylic acid, a potent mGluR1 antagonist. J Pharmacol Exp Ther 281 (1997) 721-729
43. Nicoletti F., Bruno V., Catania M.V., Battaglia G., Copani A., Barbagallo G., Cena V., Sanchez-Prieto J., Spano P.F., and Pizzi M. Group-I metabotropic glutamate receptors: hypotheses to explain their dual role in neurotoxicity and neuroprotection. Neuropharmacology 38 (1999) 1477-1484
44. Opitz T., and Reymann K.G. (1S, 3R)-ACPD protects synaptic transmission from hypoxia in hippocampal slices. Neuropharmacology 32 (1993) 103-104
45. Pizzi M., Consolandi O., Memo M., and Spano P.F. Activation of multiple metabotropic glutamate receptor subtypes prevents NMDA-induced excitotoxicity in rat hippocampal slices. Eur J Neurosci 8 (1996) 1516-1521
46. Pizzi M., Galli P., Consolandi O., Arrighi V., Memo M., and Spano P.F. Metabotropic and ionotropic transducers of glutamate signal inversely control cytoplasmic Ca2+ concentration and excitotoxicity in cultured cerebellar granule cells: pivotal role of protein kinase C. Mol Pharmacol 49 (1996) 586-594
47. Plaitakis A. Glutamate dysfunction and selective motor neuron degeneration in amyotrophic lateral sclerosis: a hypothesis. Ann Neurol 28 (1990) 3-8
48. Reiner A., Medina L., Figueredo-Cardenas G., and Anfinson S. Brainstem motoneuron pools that are selectively resistant in amyotrophic lateral sclerosis are preferentially enriched in parvalbumin: evidence from monkey brainstem for a calcium-mediated mechanism in sporadic ALS. Exp Neurol 131 (1995) 239-250
49. Ross M.A. Acquired motor neuron disorders. Neurol Clin 15 (1997) 481-500
50. Rothstein J.D. Excitotoxic mechanisms in the pathogenesis of amyotrophic lateral sclerosis. Adv Neurol 68 (1995) 7-20
51. Rothstein J.D., Dykes-Hoberg M., Pardo C.A., Bristol L.A., Jin L., Kuncl R.W., Kanai Y., Hediger M.A., Wang Y., Schielke J.P., and Welty D.F. Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate. Neuron 16 (1996) 675-686
52. Rothstein J.D., Martin L.J., and Kunci R.W. Decreased glutamate transport by the brain and spinal cord in amyotrophic lateral sclerosis. N Engl J Med 326 (1992) 1464-1468
53. Rothstein J.D., Patel S., Regan M.R., Haenggeli C., Huang Y.H., Bergles D.E., Jin L., Dykes Hoberg M., Vidensky S., Chung D.S., Toan S.V., Bruijn L.I., Su Z.Z., Gupta P., and Fisher P.B. Beta-lactam antibiotics offer neuroprotection by increasing glutamate transporter expression. Nature 433 (2005) 73-77
54. Rothstein J.D., Van Kammen M., Levey A.I., Martin L.J., and Kuncl R.W. Selective loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis. Ann Neurol 38 (1995) 73-84
55. Sacaan A.I., and Schoepp D.D. Activation of hippocampal metabotropic excitatory amino acid receptors leads to seizures and neuronal damage. Neurosci Lett 139 (1992) 77-82
56. Schroder U.H., Opitz T., Jager T., Sabelhaus C.F., Breder J., and Reymann K.G. Protective effect of group I metabotropic glutamate receptor activation against hypoxic/hypoglycemic injury in rat hippocampal slices: timing and involvement of protein kinase C. Neuropharmacology 38 (1999) 209-216
57. Shaw P.J. Excitotoxicity and motor neurone disease: a review of the evidence. J Neurol Sci 124 (1994) 6-13
58. Tapia R. Release and uptake of glutamate as related to excitotoxicity. Rev Bras Biol 1 (1996) 165-174
59. Tomiyama M., Kimura T., Maeda T., Tanaka H., Furusawa K., Kurahashi K., and Matsunaga M. Expression of metabotropic glutamate receptor mRNAs in the human spinal cord: implications for selective vulnerability of spinal motor neurons in amyotrophic lateral sclerosis. J Neurol Sci 189 (2001) 65-69
60. Trotti D., Aoki M., Pasinelli P., Berger U.V., Danbolt N.C., Brown Jr. R.H., and Hediger M.A. Amyotrophic lateral sclerosis-linked glutamate transporter mutant has impaired glutamate clearance capacity. J Biol Chem 276 (2001) 576-582
61. Ugolini A., Corsi M., and Bordi F. Potentiation of NMDA and AMPA responses by group I mGluR in spinal cord motoneurons. Neuropharmacology 36 (1997) 1047-1055
62. Vanselow B.K., and Keller B.U. Calcium dynamics and buffering in oculomotor neurones from mouse that are particularly resistant during amyotrophic lateral sclerosis (ALS)-related motoneurone disease. J Physiol 525 Pt 2 (2000) 433-445